Browsing by Author Ejlertsen, Bent

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 9 of 9
Issue DateTitleAuthor(s)Citation
2011Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8.1 years median follow-upCoates, Alan; Ejlertsen, Bent; Forbes, John F.; Gelber, Richard; Giobbie-Hurder, Anita; Goldhirsch, Aron; Lang, Istvan; Mauriac, Louis; Neven, Patrick; Price, Karen N.; Rabaglio, Manuela; Regan, Meredith M.; Smith, Ian (Prof); Thurlimann, B.; Wardley, Andrew; School of Public Health: Public HealthAssessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8.1 years median follow-up, Lancet Oncology, vol.12, 12, 2011,pp 1101-1108
2017Cholesterol, cholesterol-lowering medication use, and breast cancer outcome in the BIG 1-98 studyCoates, Alan; Ahern, T; Borgquist, Signe; Colleoni, Marco; Debled, Marc; Ejlertsen, Bent; et al, Various; Garber, Judy; Giobbie-Hurder, Anita; Lang, Istvan; von Moos, Roger; NH&MRC Clinical Trials CentreCholesterol, cholesterol-lowering medication use, and breast cancer outcome in the BIG 1-98 study, Journal of Clinical Oncology, vol.35, 11, 2017,pp 1179-1188
2015Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancerBoyle, Frances; Buzdar, Aman; Ejlertsen, Bent; et al, Various; Fumoleau, Pierre; Gradishar, William; Martin, Miguel; Moy, Beverly; O’Shaughnessy, Joyce; Piccart-Gebhart, Martine; Smith, Ian; Northern Clinical School: MedicineHealth related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer, European Journal of Cancer, vol.51, 6, 2015,pp 685-696
2015Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapyBoyle, Frances; Buzdar, Aman; Ejlertsen, Bent; et al, Various; Fumoleau, Pierre; Gradishar, William; Horick, Nora; Martin, Miguel; Moy, Beverly; O’Shaughnessy, Joyce; Smith, Ian (Prof); Strasser-Weippl, Kathrin; Northern Clinical School: MedicineLong-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy, Breast Cancer Research, vol.17, 1, 2015,pp 1-7
2012Obesity and Risk of Recurrence or Death After Adjuvant Endocrine Therapy With Letrozole or Tamoxifen in the Breast International Group 1-98 TrialCoates, Alan; Bonnefoi, Herve; Ejlertsen, Bent; et al, Various; Ewertz, Marianne; Forbes, John F.; Gray, Kathryn P; Paridaens, R.J.; Price, Karen N.; Rabaglio, Manuela; Regan, Meredith M.; Thurlimann, Beat; School of Public Health: Public HealthObesity and Risk of Recurrence or Death After Adjuvant Endocrine Therapy With Letrozole or Tamoxifen in the Breast International Group 1-98 Trial, Journal of Clinical Oncology, vol.30, 32, 2012,pp 3967-3975
2015Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trialCoates, Alan; Bibeau, Frederic; Ejlertsen, Bent; et al, Various; Giobbie-Hurder, Anita; Gusterson, Barry A; Lelkaitis, Gierdrius; MacGrogan, G.; Mallon, Elizabeth; Munzone, Elisabetta; Thurlimann, B.; Viale, Giuseppe; School of Public Health: Public HealthOutcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial, Annals of Oncology, vol.26, 12, 2015,pp 2442-2449
2015Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 TrialCoates, Alan; Colleoni, Marco; Debled, Marc; Ejlertsen, Bent; Filho, Otto Metzger; Gelber, Richard; Giobbie-Hurder, Anita; Goldhirsch, Aron; Gusterson, B. A.; Mallon, Elizabeth; Price, Karen N; Regan, Meredith; Thurlimann, Beat; Viale, Giuseppe; Winer, Eric P.; School of Public Health: Public HealthRelative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial, Journal of Clinical Oncology, vol.33, 25, 2015,pp 2772-2779
2014Symptoms of endocrine treatment and outcome in the BIG 1-98 studyCoates, Alan; Bonnefoi, Herve; Cole, B F; Ejlertsen, Bent; et al, Various; Forbes, John F.; Giobbie-Hurder, Anita; Huober, J; Lang, Istvan; Neven, Patrick; Rabaglio, Manuela; Wu, Junru; School of Public Health: Public HealthSymptoms of endocrine treatment and outcome in the BIG 1-98 study, Breast Cancer Research and Treatment, vol.143, 1, 2014,pp 159-169
2016Treatment adherence and its impact on disease-free survival in the breast international group 1-98 trial of tamoxifen and letrozole, alone and in sequenceCoates, Alan; Chirgwin, Jacquie; Debled, Marc; Ejlertsen, Bent; et al, Various; Gelber, Richard D; Giobbie-Hurder, Anita; Goldhirsch, Aron; Price, Karen N.; Rabaglio, Manuela; Smith, Ian; School of Public Health: Public HealthTreatment adherence and its impact on disease-free survival in the breast international group 1-98 trial of tamoxifen and letrozole, alone and in sequence, Journal of Clinical Oncology, vol.34, 21, 2016,pp 2452-2459